Atomwise uses Deep Learning Neural Networks to help discover new medicines. Atomwise achieves the world’s best results for new drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise predicts drug candidates for pharmaceutical companies, startups, and research institutions. The Company's tools can tell the difference between great drug candidates and toxic ones, and discover new uses for old medicines.

San Francisco, US
Size (employees)
14 (est)+17%
Atomwise was founded in 2012 and is headquartered in San Francisco, US
Report incorrect company information

Atomwise Office Locations

Atomwise has an office in San Francisco
Show all (1)
Report incorrect company information

Atomwise Financials and Metrics

Summary Metrics

Atomwise's latest funding round in March 2018 was reported to be $45 m. In total, Atomwise has raised $51.6 m
Report incorrect company information